Vascular Graft Solutions today announced that it received CE Mark approval for its Frame FR external support for AV fistula repair.
“We are excited to launch the Frame FR platform, a holistic solution for repair, stabilization and prevention of recurrent vascular access disease,” founder and CEO Eyal Orion said in a press release. “In the past 10 years, we have become a global leader in developing and commercializing external supports for prevention of vein graft disease in coronary and peripheral bypass. After extensive pre-clinical and clinical research, we are glad to expand our solutions to hemodialysis patients and hope to address one of the leading causes of morbidity and mortality in these patients – the toxic effect of the vascular access on the heart.”